Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Cardiovascular Risk and DiseasesLipid-Lowering Drugs

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study

Lancet Diabetes Endocrinol.

Raal FJ, Hovingh GK, Blom D, Santos RD, Harada-Shiba M, Bruckert E, Couture P, Soran H, Watts GF, Kurtz C, Honarpour N, Tang L, Kasichayanula S, Wasserman SM, Stein EA

doi: 10.1016/S2213-8587

Cardiovascular Risk and DiseasesAtrial FibrillationHeart FailureHypertensionMyocardial InfarctionThrombosis and Stroke

Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study

Lancet Diabetes Endocrinol.

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A

RECOMMENDED

Lipid-Lowering Drugs

Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/
ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

J Am Coll Cardiol.

Wilson PWF, Polonsky TS, Miedema MD, Khera A, Kosinski AS, Kuvin JT

doi: 10.1016/j.jacc.2018.11.004.

Cardiac Arrest or DeathAtrial FibrillationHeart, Artery and Coronary DiseasesHeart Failure

Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Heart Rhythm.

Kusumoto FM, Bailey KR, Chaouki AS, Deshmukh AJ, Gautam S, Kim RJ, Kramer DB, Lambrakos LK, Nasser NH, Sorajja D

doi: 10.1016/j.hrthm.2017.10.037.

RECOMMENDED

Cardiovascular Risk and Diseases

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

★ 3 Recommended by Prof. Dr Isabella Sudano, Faculty Member

Lancet

EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

doi: 10.1016/S0140-6736(21)01122-3

RECOMMENDED

Cardiovascular Risk and DiseasesLipid-Lowering Drugs

Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study

★ 3 Recommended by Prof. Dr Isabella Sudano, Faculty Member

doi: 10.1016/j.jacc.2020.03.025.

Cardiovascular Risk and DiseasesAtrial FibrillationHeart, Artery and Coronary DiseasesHeart FailureHypertensionThrombosis and Stroke

Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis

Lancet Diabetes Endocrinol.

Monticone S, D'Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P

RECOMMENDED

Cardiovascular Risk and DiseasesLipid-Lowering Drugs

PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

★ 3 Recommended by Prof. Dr Isabella Sudano, Faculty Member

Cochrane Database Syst Rev

Schmidt AF, Carter JL, Pearce LS, Wilkins JT, Overington JP, Hingorani AD, Casas JP

doi: 10.1002/14651858.CD011748.pub3

Heart, Artery and Coronary Diseases

Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis: A Systematic Review

JAMA Cardiol.

Luoma LM, Westerhout CM, Granger CB, Armstrong PW

doi: 10.1001/jamacardio.

Related content

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study

Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study

Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study

Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis

PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis: A Systematic Review

Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/
ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines